Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH

Thyroid

Volumn 16, Issue 12, 2006, Pages 1195-1206

  Sanders, Jane ^a   Bolton, Jane ^a   Sanders, Paul ^a   Jeffreys, Jennifer ^a   Nakatake, Nobuhiro ^a   Richards, Tonya ^a   Evans, Michele ^a   Kiddie, Angela ^a   Summerhayes, Sara ^a   Roberts, Emma ^a   Miguel, Ricardo Núñez ^a,b   Furmaniak, Jadwiga ^a   Smith, Bernard Rees ^a  

^a RSR LTD   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLIC AMP; LEUCINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY M22; MONOCLONAL ANTIBODY R255; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROTROPIN RECEPTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; DRUG ACTIVITY; EPITOPE MAPPING; GENE MUTATION; GRAVES DISEASE; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; THYROTROPIN RELEASE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; GRAVES DISEASE; HUMANS; MICE; MODELS, MOLECULAR; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, THYROTROPIN; THYROTROPIN; TRANSFECTION;

EID: 33846156211     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.1195     Document Type: Article

References (28)

1. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM 1998 The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 19:673-716.
2. Smits G, Govaerts C, Nubourgh I, Pardo L, Vassart G, Costagliola S 2002 Lysine 183 and glutamic acid 157 of the TSH receptor: two interacting residues with a key role in determining specificity toward TSH and human CG. Mol Endocrinol 16:722-735.
3. Smits G, Campillo M, Govaerts C, Janssens V, Richter C, Vassart G, Pardo L, Costagliola S 2003 Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. EMBO J 22:2692-2703.
4. Sanders J, Evans M, Premawardhana LDKE, Depraetere H, Jeffreys J, Richards T, Furmaniak J, Rees Smith B 2003 Human monoclonal thyroid stimulating autoantibody. Lancet 362:126-128.
5. Sanders J, Jeffreys J, Depraetere H, Evans M, Richards T, Kiddie A, Brereton K, Premawardhana LDKE, Chirgadze DY, Núñez Miguel R, Blundell TL, Furmaniak J, Rees Smith B 2004 Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. Thyroid 14:560-570.
6. Sanders J, Jeffreys J, Depraetere H, Richards T, Evans M, Kiddie A, Brereton K, Groenen M, Oda Y, Furmaniak J, Rees Smith B 2002 Thyroid-stimulating monoclonal antibodies. Thyroid 12:1043-1050.
7. Ando T, Latif R, Pritsker A, Moran T, Nagayama Y, Davies TF 2002 A monoclonal thyroid-stimulating antibody. J Clin Invest 110:1667-1674.
8. Costagliola S, Bonomi M, Morgenthaler NG, Van Durme J, Panneels V, Refetoff S, Vassart G 2004 Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity. Mol Endocrinol 18:3020-3034.
9. Oda Y, Sanders J, Roberts S, Maruyama M, Kato R, Perez M, Petersen VB, Wedlock N, Furmaniak J, Rees Smith B 1998 Binding characteristics of antibodies to the TSH receptor. J Mol Endocrinol 20:233-244.
10. Sanger F, Nicklen S, Coulson AR 1977 DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467.
11. 125I-labeled TSH receptor. J Clin Endocrinol Metab 84:3797-3802.
12. Hashim FA, Creagh FM, El Hawrani A, Parkes AB, Buckland PR, Rees Smith B 1986 Characterization of TSH antagonist activity in the serum of patients with thyroid disease. Clin Endocrinol 25:275-281.
13. Sanders J, Allen F, Jeffreys J, Bolton J, Richards T, Depraetere H, Nakatake N, Evans M, Kiddie A, Premawardhana LDKE, Chirgadze DY, Núñez Miguel R, Blundell TL, Furmaniak J, Rees Smith B 2005 Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist. Thyroid 15:672-682.
14. Scatchard C 1949 The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:660-672.
15. Jeffreys J, Depraetere H, Sanders J, Oda Y, Evans M, Kiddie A, Richards T, Furmaniak J, Rees Smith B 2002 Characterization of the thyrotropin binding pocket. Thyroid 12:1051-1061.
16. Sugawa H, Akamizu T, Kosugi S, Ueda Y, Ohta C, Okuda J, Mori T 1995 Presence of heterogeneous thyroid-stimulating antibodies in sera from individual Graves' patients as shown by synthesized thyrotropin receptor peptide application: evidence showing two independent epitopes and a possible recognition of two epitopic regions by one antibody molecule. Eur J Endocrinol 133:283-293.
17. Piraphatdist T, Sugawa H, Inoue D, Enomoto T, Mori T, Imura H 1990 Possible binding site of thyrotropin binding inhibitor immunoglobulin (TBII) on the thyrotropin (TSH) receptor, which is different from TSH binding site. Biochem Biophys Res Commun 172:529-536.
18. Ikeda M, Ohmori M, Endo T, Onaya T 1993 Immunodetection of TSH receptor antibodies in sera of patients with autoimmune thyroid disease by ELISA (enzyme-linked immunosorbent assay). Acta Endocrinol (Copenh) 128:126-130.
19. Morris JC, Gibson JL, Haas EJ, Bergert ER, Dallas JS, Prabhakar BS 1994 Identification of epitopes and affinity purification of thyroid stimulating auto-antibodies using synthetic human TSH receptor peptides. Autoimmunity 17:287-299.
20. Chazenbalk GD, Jaume JC, McLachlan SM, Rapoport B 1997 Engineering the human thyrotropin receptor ectodomain from a non-secreted form to a secreted, highly immunoreactive glycoprotein that neutralizes autoantibodies in Graves' patients' sera. J Biol Chem 272:18959-18965.
21. Chazenbalk GD, Wang Y, Guo J, Hutchinson JS, Segal D, Jaume JC, McLachlan SM, Rapoport B 1999 A mouse monoclonal antibody to a thyrotropin receptor ectodomain variant provides insight into the exquisite antigenic conformational requirement, epitopes and in vivo concentration of human autoantibodies. J Clin Endocrinol Metab 84:702-710.
22. Oda Y, Sanders J, Evans M, Kiddie A, Munkley A, James C, Richards T, Wills J, Furmaniak J, Rees Smith B 2000 Epitope analysis of the human thyrotropin (TSH) receptor using monoclonal antibodies. Thyroid 10:1051-1059.
23. Núñez Miguel R, Sanders J, Jeffreys J, Depraetere H, Evans M, Richards T, Blundell TL, Rees Smith B, Furmaniak J 2004 Analysis of the thyrotropin receptor-thyrotropin interaction by comparative modeling. Thyroid 14:991-1011.
24. Kiukuoka S, Shimojo N, Yamaguchi K-I, Watanabe Y, Hoshioka A, Hirai A, Saito Y, Tahara K, Kohn LD, Maruyama N, Kohno Y, Niimi H 1998 The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain. Endocrinology 139:1891-1898.
25. Bryant WP, Bergert ER, Morris JC 1995 Identification of thyroid blocking antibodies and receptor epitopes in autoimmune hyopthyroidism by affinity purification using synthetic TSH receptor peptides. Autoimmunity 22:69-79.
26. Rees Smith B, McLachlan SM, Furmaniak J 1988 Autoantibodies to the thyrotropin receptor. Endocr Rev 9:106-121.
27. Morgenthaler NG, Minich WB, Willnich M, Bogusch T, Hollidt JM, Weglöhner W, Lenzner C, Bergmann A 2003 Affinity purification and diagnostic use of TSH receptor autoantibodies from human serum. Mol Cell Endocr 212:73-79.
28. Kohn LD, Harii N 2003 Thyrotropin receptor autoantibodies (TSHRAbs): epitopes, origins and clinical significance. Autoimmunity 36:331-337.